IKAP Short Positions, Funds Shorting Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.
DE ˙ DB ˙ CA05156V1022
€ 10,34 ↓ −0,15 (−1,43%)
2025-09-10
AKSJEKURSEN
Fonds shorting Aurinia Pharmaceuticals Inc.

Denne siden viser institusjoner, fonds og hovedaksjonærer som har rapportert short-posisjoner i deres siste rapporteringsperiode. Vi betrakter .......... som short- posisjoner og inkluderer alle institusjoner som har offentliggjort putopsjoner her. Grønne rader indikerer nye posisjoner. Røde rader indikerer lukkede posisjoner. Klikk på linkikonet for å se full transaksjonshistorikk.

Oppgraderfor å låse opp premiedata.

Fildato Kilde Investor Type Gjennomsnittlig pris
(estimert)
Aksjer Δ Aksjer
(%)
Rapportert verdi ($1000) Verdi (%) Portallokering (%)
2025-08-27 13F/A Squarepoint Ops LLC Put 0 −100,00 0 −100,00
2025-08-11 13F Citigroup Inc Put 50 000 424
2025-08-12 13F Proequities, Inc. Put 0 0
2025-08-14 13F Citadel Advisors Llc Put 69 300 −45,56 587 −42,72
2025-08-14 13F Susquehanna International Group, Llp Put 145 600 −14,00 1 233 −9,40
2025-08-18 13F Wolverine Trading, Llc Put 26 000 4,42 225 8,74
2025-08-14 13F Group One Trading, L.p. Put 91 000 −16,05 771 −11,60
2025-08-14 13F Jane Street Group, Llc Put 122 900 −2,92 1 041 2,26
2025-05-08 13F Jefferies Financial Group Inc. Put 0 −100,00 0 −100,00
2025-08-05 13F Simplex Trading, Llc Put 118 400 52,19 1
2025-08-13 13F Walleye Capital LLC Put 11 300 28,41 96 35,71
2025-08-14 13F Caption Management, LLC Put 240 500 −23,77 2 037 −19,68
Other Listings
US:AUPH USD 12,22
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista